Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 57.25
+0.75 (1.33%)
At close: Nov 5, 2025
Shanghai OPM Biosciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 43.24 | 21.05 | 54.04 | 105.37 | 60.39 | 11.68 | Upgrade |
Depreciation & Amortization | 45.56 | 45.68 | 36.83 | 33.85 | 28.19 | 15.49 | Upgrade |
Other Amortization | 12.51 | 12.39 | 5.88 | 5.17 | 4.07 | 2.81 | Upgrade |
Loss (Gain) From Sale of Assets | -0.09 | -0.09 | - | -0.29 | - | 0 | Upgrade |
Asset Writedown & Restructuring Costs | 7.51 | 7.51 | 0.02 | 0 | 0.02 | - | Upgrade |
Loss (Gain) From Sale of Investments | -18.25 | -18.25 | -14.59 | -5.81 | -4.18 | -1.44 | Upgrade |
Provision & Write-off of Bad Debts | 6.92 | 6.92 | 6.42 | 4.76 | 0.31 | 0.1 | Upgrade |
Other Operating Activities | 18.72 | -0.6 | 1.99 | 3.01 | 5.11 | 3.1 | Upgrade |
Change in Accounts Receivable | -39.23 | -39.23 | -24.83 | -46.04 | -6.3 | -34.1 | Upgrade |
Change in Inventory | -9.41 | -9.41 | -5.62 | -10.56 | -21.26 | 3.12 | Upgrade |
Change in Accounts Payable | 38.54 | 38.54 | -8.16 | 16.82 | 40.52 | -1.62 | Upgrade |
Change in Other Net Operating Assets | 5.5 | 5.5 | 6.87 | 5.79 | 7.87 | 4.08 | Upgrade |
Operating Cash Flow | 110.76 | 69.25 | 57.95 | 111.62 | 114.63 | 3.2 | Upgrade |
Operating Cash Flow Growth | 33.89% | 19.49% | -48.08% | -2.62% | 3478.75% | -81.43% | Upgrade |
Capital Expenditures | -89.55 | -120.86 | -77.55 | -146.96 | -105.98 | -36.24 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 6.78 | - | - | Upgrade |
Cash Acquisitions | - | - | 0.02 | - | - | - | Upgrade |
Investment in Securities | -231.73 | -253.73 | -73.26 | -283.28 | -38 | - | Upgrade |
Other Investing Activities | 65.78 | 4.05 | 1.25 | 37.87 | 3.99 | -68.64 | Upgrade |
Investing Cash Flow | -255.5 | -370.54 | -149.53 | -385.59 | -139.99 | -104.88 | Upgrade |
Long-Term Debt Issued | - | - | - | 32.34 | 42.82 | 15 | Upgrade |
Long-Term Debt Repaid | - | -11.3 | -45.42 | -62.79 | -21.6 | -23.5 | Upgrade |
Net Debt Issued (Repaid) | -11.3 | -11.3 | -45.42 | -30.45 | 21.22 | -8.5 | Upgrade |
Issuance of Common Stock | - | - | - | 1,523 | - | 399.79 | Upgrade |
Repurchase of Common Stock | -37.38 | -37.25 | -13.75 | - | - | - | Upgrade |
Common Dividends Paid | -49.48 | -51.22 | -73.83 | -2.08 | -1.8 | -2.14 | Upgrade |
Other Financing Activities | 42.69 | 0.13 | - | -15.74 | 0.2 | -4.27 | Upgrade |
Financing Cash Flow | -55.47 | -99.64 | -133.01 | 1,474 | 19.62 | 384.88 | Upgrade |
Foreign Exchange Rate Adjustments | 1.74 | 2.42 | 0.95 | 2.35 | -0.24 | -0.53 | Upgrade |
Net Cash Flow | -198.47 | -398.51 | -223.64 | 1,203 | -5.99 | 282.67 | Upgrade |
Free Cash Flow | 21.21 | -51.61 | -19.59 | -35.34 | 8.64 | -33.04 | Upgrade |
Free Cash Flow Margin | 6.01% | -17.36% | -8.06% | -12.01% | 4.06% | -26.44% | Upgrade |
Free Cash Flow Per Share | 0.18 | -0.44 | -0.17 | -0.35 | 0.10 | -0.38 | Upgrade |
Cash Income Tax Paid | 45.57 | 29.9 | 11.38 | 28.47 | 13.42 | -1.1 | Upgrade |
Levered Free Cash Flow | -353.26 | -48.83 | -38.18 | -100.94 | -34.34 | -42.19 | Upgrade |
Unlevered Free Cash Flow | -352.8 | -46.88 | -36.16 | -97.83 | -31.35 | -40.66 | Upgrade |
Change in Working Capital | -5.37 | -5.37 | -32.64 | -34.44 | 20.7 | -28.53 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.